BIOLOGICAL THERAPY SURVIVAL RATE IN A CANADIAN COHORT OF RHEUMATOID ARTHRITIS PATIENTS

被引：0
|
作者：
Rioux, E. [1 ]
Rioux, M. -J. [1 ]
Fortin, I. [1 ]
机构：
[1] Ctr Rhumatol Est Quebec, Rimouski, PQ, Canada
来源：
ANNALS OF THE RHEUMATIC DISEASES | 2014年 / 73卷
关键词：
D O I：
10.1136/annrheumdis-2014-eular.3681
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
FRI0312
引用
收藏
页码：498 / 498
页数：1
相关论文
共 50 条
  • [41] SARCOPENIC PHENOTYPE AND PHYSICAL PERFORMANCE IN RHEUMATOID ARTHRITIS PATIENTS WITH BIOLOGICAL THERAPY
    Dobrovolskaya, O.
    Demin, N.
    Feklistov, A.
    Kozyreva, M.
    Toroptsova, N.
    AGING CLINICAL AND EXPERIMENTAL RESEARCH, 2024, 36 : S462 - S462
  • [42] SUBJECTIVE HEALTH EXPECTATIONS OF RHEUMATOID ARTHRITIS PATIENTS STARTING BIOLOGICAL THERAPY
    Gulacsi, L.
    Brodszky, V
    Baji, P.
    Gulacsi, L. A.
    Pentek, M.
    VALUE IN HEALTH, 2011, 14 (07) : A312 - A313
  • [43] IMPACT OF TWO BIOLOGICAL TREATMENTS IN THE FUNCTIONAL CAPACITY OF A COHORT OF PATIENTS WITH RHEUMATOID ARTHRITIS
    Martinez-Perez, R.
    Rodriguez-Montero, S.
    Munoz, A.
    Leon, M.
    Gallo, F.
    Velloso, M. L.
    Marenco, J. L.
    ANNALS OF THE RHEUMATIC DISEASES, 2011, 70 : A89 - A89
  • [44] PATTERNS OF CHANGE OFA SECOND BIOLOGICAL DMARD IN A COHORT OF RHEUMATOID ARTHRITIS PATIENTS
    Rolon Campuzano, R.
    Coronel Ale, A. L.
    Cerda, O. L.
    Dal Pra, F.
    Schneeberger, E. E.
    Correa, M. A.
    Rosemffet, M. G.
    Buschiazzo, E.
    Garcia Salinas, R.
    Papasidero, S. B.
    Barrios, B. I.
    Maldonado, Ficco H.
    Citera, G.
    JCR-JOURNAL OF CLINICAL RHEUMATOLOGY, 2018, 24 : S4 - S4
  • [45] WHAT FACTORS ARE ASSOCIATED WITH THE EVOLUTION TOWARDS RHEUMATOID ARTHRITIS, USE OF BIOLOGICAL THERAPY AND DEVELOPMENT OF CARDIOVASCULAR EVENTS IN A COHORT OF PATIENTS WITH UNDIFFERENTIATED ARTHRITIS?
    Calvo Gutierrez, Jerusalem
    Ortega Castro, Rafaela
    Lopez-Medina, Clementina
    Pineda Lourdes, Ladehesa
    Castro Villegas, Maria del Carmen
    Escudero Contreras, Alejandro
    Collantes Estevez, Eduardo
    ANNALS OF THE RHEUMATIC DISEASES, 2019, 78 : 1575 - 1575
  • [46] Survival of patients after lymphocytotoxic monoclonal antibody therapy for rheumatoid arthritis
    Isaacs, JD
    Clarke, AM
    Hazleman, BL
    Hale, G
    Waldmann, H
    Symmons, DPM
    ARTHRITIS AND RHEUMATISM, 2004, 50 (09): : S700 - S701
  • [47] TNF-α Antagonist Survival Rate in a Cohort of Rheumatoid Arthritis Patients Observed under Conditions of Standard Clinical Practice
    Marchesoni, Antonio
    Zaccara, Eleonora
    Gorla, Roberto
    Bazzani, Chiara
    Sarzi-Puttini, Piercarlo
    Atzeni, Fabiola
    Caporali, Roberto
    Bobbio-Pallavicini, Francesca
    Favalli, Ennio Giulio
    CONTEMPORARY CHALLENGES IN AUTOIMMUNITY, 2009, 1173 : 837 - 846
  • [48] BIOLOGICAL THERAPY OPTIMIZATION IN PATIENTS WITH MODERATE TO SEVERE RHEUMATOID ARTHRITIS. ANALYSIS OF EFFECTIVENESS IN A COHORT OF PATIENTS IN CLINICAL PRACTICE CONDITIONS
    Montero, S. Rodriguez
    Feijoo, M. L. Velloso
    Almeida, C., V
    ANNALS OF THE RHEUMATIC DISEASES, 2024, 83
  • [49] SURVIVAL OF SYNTHETIC AND BIOLOGICAL DMARD THERAPY IN RHEUMATOID ARTHRITIS: RESULTS OF DAILY CLINICAL PRACTICE
    Rojas-Zuleta, W. G.
    Pantoja-Marquez, A. E.
    Vasquez, M.
    Duque-Zapata, N.
    Orozco, C.
    JCR-JOURNAL OF CLINICAL RHEUMATOLOGY, 2018, 24 : S75 - S75
  • [50] BIOLOGICAL THERAPIES SURVIVAL FOR RHEUMATOID ARTHRITIS, PSORIATIC ARTHRITIS SPONDYLOARTHRITIS AND JUVENILE ONSET ARTHRITIS. A COHORT STUDY FROM BIOBADAGUAY
    Avila, G.
    Cabrera-Villalba, S.
    Melgarejo, P.
    Roman, L.
    Morel, Z.
    Rolon, R.
    Zarza, M.
    Estevez, M. Soto
    Leiva, E.
    Amarilla, A.
    Pusineri, P.
    Parodi, C.
    Diaz, C.
    Acevedo, B.
    Fernandez, A.
    Valinotti, V.
    Trigueros, P. De Abreu
    ANNALS OF THE RHEUMATIC DISEASES, 2023, 82 : 1405 - 1405
12345